Literature DB >> 19002211

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.

Robert Lyle1, Frédérique Béna, Sarantis Gagos, Corinne Gehrig, Gipsy Lopez, Albert Schinzel, James Lespinasse, Armand Bottani, Sophie Dahoun, Laurence Taine, Martine Doco-Fenzy, Pascale Cornillet-Lefèbvre, Anna Pelet, Stanislas Lyonnet, Annick Toutain, Laurence Colleaux, Jürgen Horst, Ingo Kennerknecht, Nobuaki Wakamatsu, Maria Descartes, Judy C Franklin, Lina Florentin-Arar, Sophia Kitsiou, Emilie Aït Yahya-Graison, Maher Costantine, Pierre-Marie Sinet, Jean M Delabar, Stylianos E Antonarakis.   

Abstract

Down syndrome (DS) is one of the most frequent congenital birth defects, and the most common genetic cause of mental retardation. In most cases, DS results from the presence of an extra copy of chromosome 21. DS has a complex phenotype, and a major goal of DS research is to identify genotype-phenotype correlations. Cases of partial trisomy 21 and other HSA21 rearrangements associated with DS features could identify genomic regions associated with specific phenotypes. We have developed a BAC array spanning HSA21q and used array comparative genome hybridization (aCGH) to enable high-resolution mapping of pathogenic partial aneuploidies and unbalanced translocations involving HSA21. We report the identification and mapping of 30 pathogenic chromosomal aberrations of HSA21 consisting of 19 partial trisomies and 11 partial monosomies for different segments of HSA21. The breakpoints have been mapped to within approximately 85 kb. The majority of the breakpoints (26 of 30) for the partial aneuploidies map within a 10-Mb region. Our data argue against a single DS critical region. We identify susceptibility regions for 25 phenotypes for DS and 27 regions for monosomy 21. However, most of these regions are still broad, and more cases are needed to narrow down the phenotypic maps to a reasonable number of candidate genomic elements per phenotype.

Entities:  

Mesh:

Year:  2008        PMID: 19002211      PMCID: PMC2986205          DOI: 10.1038/ejhg.2008.214

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  50 in total

1.  The DNA sequence of human chromosome 21.

Authors:  M Hattori; A Fujiyama; T D Taylor; H Watanabe; T Yada; H S Park; A Toyoda; K Ishii; Y Totoki; D K Choi; Y Groner; E Soeda; M Ohki; T Takagi; Y Sakaki; S Taudien; K Blechschmidt; A Polley; U Menzel; J Delabar; K Kumpf; R Lehmann; D Patterson; K Reichwald; A Rump; M Schillhabel; A Schudy; W Zimmermann; A Rosenthal; J Kudoh; K Schibuya; K Kawasaki; S Asakawa; A Shintani; T Sasaki; K Nagamine; S Mitsuyama; S E Antonarakis; S Minoshima; N Shimizu; G Nordsiek; K Hornischer; P Brant; M Scharfe; O Schon; A Desario; J Reichelt; G Kauer; H Blocker; J Ramser; A Beck; S Klages; S Hennig; L Riesselmann; E Dagand; T Haaf; S Wehrmeyer; K Borzym; K Gardiner; D Nizetic; F Francis; H Lehrach; R Reinhardt; M L Yaspo
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

3.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

4.  Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain.

Authors:  Rong Mao; Carol L Zielke; H Ronald Zielke; Jonathan Pevsner
Journal:  Genomics       Date:  2003-05       Impact factor: 5.736

5.  DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones.

Authors:  Heike Fiegler; Philippa Carr; Eleanor J Douglas; Deborah C Burford; Sarah Hunt; Carol E Scott; James Smith; David Vetrie; Patricia Gorman; Ian P M Tomlinson; Nigel P Carter
Journal:  Genes Chromosomes Cancer       Date:  2003-04       Impact factor: 5.006

6.  Transcriptome analysis of human autosomal trisomy.

Authors:  David R FitzPatrick; Jacqueline Ramsay; Niolette I McGill; Mary Shade; Andrew D Carothers; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2002-12-15       Impact factor: 6.150

7.  Global disruption of the cerebellar transcriptome in a Down syndrome mouse model.

Authors:  Nidhi G Saran; Mathew T Pletcher; JoAnne E Natale; Ying Cheng; Roger H Reeves
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

8.  Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes.

Authors:  E Aït Yahya-Graison; J Aubert; L Dauphinot; I Rivals; M Prieur; G Golfier; J Rossier; L Personnaz; N Creau; H Bléhaut; S Robin; J M Delabar; M-C Potier
Journal:  Am J Hum Genet       Date:  2007-07-19       Impact factor: 11.025

9.  Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance.

Authors:  Paola Prandini; Samuel Deutsch; Robert Lyle; Maryline Gagnebin; Celine Delucinge Vivier; Mauro Delorenzi; Corinne Gehrig; Patrick Descombes; Stephanie Sherman; Franca Dagna Bricarelli; Chiara Baldo; Antonio Novelli; Bruno Dallapiccola; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2007-06-20       Impact factor: 11.025

10.  Down syndrome congenital heart disease: a narrowed region and a candidate gene.

Authors:  G M Barlow; X N Chen; Z Y Shi; G E Lyons; D M Kurnit; L Celle; N B Spinner; E Zackai; M J Pettenati; A J Van Riper; M J Vekemans; C H Mjaatvedt; J R Korenberg
Journal:  Genet Med       Date:  2001 Mar-Apr       Impact factor: 8.822

View more
  102 in total

Review 1.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

2.  The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.

Authors:  Liron Abuhatzira; Alon Shamir; Dustin E Schones; Alejandro A Schäffer; Michael Bustin
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

3.  Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A.

Authors:  R Oegema; A de Klein; A J Verkerk; R Schot; B Dumee; H Douben; B Eussen; L Dubbel; P J Poddighe; I van der Laar; W B Dobyns; P J van der Spek; M H Lequin; I F M de Coo; M-C Y de Wit; M W Wessels; G M S Mancini
Journal:  Mol Syndromol       Date:  2010-09-14

4.  Phenotypic consequences of aneuploidy in Arabidopsis thaliana.

Authors:  Isabelle M Henry; Brian P Dilkes; Eric S Miller; Diana Burkart-Waco; Luca Comai
Journal:  Genetics       Date:  2010-09-27       Impact factor: 4.562

5.  Down Syndrome - Genetics and Cardiogenetics.

Authors:  Vasilica Plaiasu
Journal:  Maedica (Bucur)       Date:  2017-09

6.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

Review 7.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

8.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining.

Authors:  Jeroen L A Pennings; Maria P H Koster; Wendy Rodenburg; Peter C J I Schielen; Annemieke de Vries
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

10.  A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome.

Authors:  Patricia Lopes Pereira; Laetitia Magnol; Ignasi Sahún; Véronique Brault; Arnaud Duchon; Paola Prandini; Agnès Gruart; Jean-Charles Bizot; Bernadette Chadefaux-Vekemans; Samuel Deutsch; Fabrice Trovero; José María Delgado-García; Stylianos E Antonarakis; Mara Dierssen; Yann Herault
Journal:  Hum Mol Genet       Date:  2009-09-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.